Cytotoxic T lymphocytes in human immunodeficiency virus type-1 infection important or impotent?

Clinical and Applied Immunology Reviews

Volumn 1, Issue 1, 2000, Pages 17-36

  Gamberg, Jane ^a   Grant, Michael ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

AIDS; Cytotoxic T lymphocytes; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; NEUTRALIZING ANTIBODY; T LYMPHOCYTE RECEPTOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; CELL MEDIATED CYTOTOXICITY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE SYSTEM; MOLECULAR MECHANICS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TREATMENT FAILURE; VIRUS IMMUNITY; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 1642379992     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(00)00004-0     Document Type: Review

References (143)

1. R. Zinkernagel P. Doherty Restriction of an in vitro T cell mediated cytotoxicity in lymphocytic choriomeningitis within asyngeneic or semiallogeneic system Nature 248 1974 701-702
2. D. Kagi P. Seiler J. Pavlovic B. Ledermann K. Burki R.M. Zinkernagel H. Hengartner The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses Eur J Immunol 25 1995 3256-3262
3. R. Zinkernagel P. Doherty H-2 compatibility requirement for T cell mediated lysis of target cells infected with lymphocytic choriomeningitis virus J Exp Med 141 1975 1427-1436
4. A. McMichael F. Gotch G. Noble P. Beare Cytotoxic T cell immunity to influenza New Eng J Med 309 1983 13-17
5. E.A. Walter P.D. Greenberg M.J. Gilbert R.J. Finch K.S. Watanabe E.D. Thomas S.R. Riddell Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T cell clones from the donor New Eng J Med 333 1995 1038-1044
6. C. Rooney C. Smith C. Ng S. Loftin C. Li R.A. Krance M.K. Brenner H.E. Heslop Use of gene-modified virus-specific T lymphocytes to control EBV-related lymphoproliferation Lancet 345 1995 9-13
7. R. Zinkernagel H. Hengartner T-cell-mediated immunopathology versus direct cytoloysis by virus implications for HIV and AIDS Immunology Today 15 1994 262-268
8. B. Walker S. Chakrabarti B. Moss T.J. Paradis T. Flynn A.G. Durno R.S. Blumberg J.C. Kaplan M.S. Hirsch R.T. Schooley HIV-specific cytotoxic T lymphocytes in seropositive individuals Nature 328 1987 245-348
9. + cytotoxic T lymphocytes specific for HTLV-1 pX in patients with HTLV-1 associated neurological disease Nature 348 1990 245-248
10. R. Johnson A. Trocha L. Yang G.P. Mazzara D.L. Panicali T.M. Buchanan B.D. Walker HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes fine specificity of the gag-specific response by using unstimulated peripheral blood mononuclear cells and cloned effector cells J Immunol 147 1991 1512-1521
11. S. Lamhamedi-Cherradi B. Culmann-Penciolelli B. Guy M.P. Kieny F. Dreyfus A.G. Saimot D. Sereni D. Sicard J.P. Levy E. Gomard Qualitative and quantitative analysis of human cytolytic T lymphocyte responses to HIV-1 proteins AIDS 6 1992 1249-1258
12. T. Harrer E. Harrer S. Kalams P. Barbosa A. Trocha R.P. Johnson T. Elbeik M.B. Feinberg S.P. Buchbinder B.D. Walker Cytotoxic T lymphocytes in asymptomatic long-term non-progressing HIV-1 infection J Immonol 156 1996 2616-2623
13. P. Goulder R. Phillips R. Colbert S. McAdam G. Ogg M.A. Nowak P. Giangrande G. Luzzi B. Morgan A. Edwards A.J. McMichael S. Rowland-Jones Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS Nature Med 3 1997 212-217
14. A. McMichael B. Walker Cytotoxic T lymphocyte epitopes implications for HIV vaccines AIDS 8 1994 S155-S173
15. Korber B, Koup R, Walker B, Haynes B, Moore J, Myers G. HIV Mol Immunol Database. Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, 1995.
16. S. Koenig T. Fuerst L.V. Wood R.M. Woods J.A. Suzich G.M. Jones V.F. de la Cruz R.J. Davey S. Venkatesan B. Moss Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein J Immunol 145 1990 127-135
17. F. Hadida G. Haas N. Zimmerman A. Hosmalin R. Spohn A. Samri G. Jung P. Debre B. Autran CTLs from lymphoid organs recognise an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 nef J Immunol 154 1995 4174-4186
18. F. Buseyne G. Janvier B. Fleury D. Schmidt Y. Riviere Multispecific and heterogenous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients factors other than the MHC control the epitope specificities Clin Exp Immunol 97 1994 353-360
19. + lymphocytes during HIV-1 infection AIDS 6 1992 793-797
20. + cytotoxic T cells express CD38 and HLA-DR antigens J Immunol 150 1993 3070-3079
21. + T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment Clin Exp Immunol 115 1999 458-463
22. R. Effros Telomeres and HIV disease Microbes and infection 2 2000 69-76
23. + T cell subset and increase with loss of CD4 T cells AIDS 13 1999 1029-1033
24. + memory cytotoxic T lymphocytes (CTL) against HIV-1 with respect to expression of CD45RA/RO, CD62L and CD28 antigens Immunol Lett 66 1999 105-110
25. + T cells In press in J Clin Immunol 20 2000 175-186
26. S.P. Balk E.C. Ebert R.L. Blumenthal F.V. McDermott K.W. Wucherpfennig S.B. Landau R.S. Blumberg Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes Science 253 1991 1411-1415
27. G. Pluschke H. Taube U. Krawinkel K. Pfeffer H. Wagner M. Classen K. Deusch Oligoclonality and skewed T cell receptor Vβ gene segment expression in in vivo activated human intestinal intraepithelial T lymphocytes Immunobiol 192 1994 77-93
28. A. Couedel-Courteille R. Le Grand M. Tulliez J.G. Guillet A. Venet Direct ex vivo simian immunodeficiency virus specific cytotoxic activity detected from small intestinal intraepithelial lymphocytes of SIV-infected macaques at an advanced stage of infection J Virol 71 1996 1052-1057
29. + lymphocytosis during primary simian immunodeficiency virus infections AIDS 11 1997 959-965
30. J. Taunk A.I. Roberts E.C. Ebert Spontaneous cytotoxicity of human intraepithelial lymphocytes against epithelial cell tumors Gastroenterology 102 1992 69-75
31. + human T cells J Immunol 157 1996 4771-4780
32. A. De Maria A. Ferraris M. Guastella S. Pilia C. Cantoni L. Polero M.C. Mingari D. Bassetti A.S. Fauci L. Moretta Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes Impairment of specific cytolytic functions Proc Natl Acad Sci USA 94 1997 10285-10288
33. M.D. Galiani E. Aguado R. Tarazona P. Romero I. Molina M. Santamaria R. Solana J. Pena Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals Clin Exp Immunol 115 1999 472-476
34. L. Ginaldi M. De Martinis A. D'Ostilio A. Di Gennaro L. Marini D. Quaglino Altered lymphocyte antigen expression in HIV infection a study by quantitative flow cytometry Am J Clin Pathol 108 1997 585-592
35. L.A. Trimble J. Lieberman Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and down-modulate CD3 zeta, the signaling chain of the T-cell receptor complex Blood 91 1998 585-594
36. H. Nakagomi M. Petersson I. Magnusson C. Juhlin M. Matsuda H. Mellstedt J.L. Taupin E. Vivier P. Anderson R. Kiessling Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma Cancer Res 53 1993 5610-5612
37. H. Aladdin H. Ullum A. Lepri H. Leffers T. Katzenstein J. Gerstoft S.B. Gjedde A.N. Phillips P. Skinhoj B.K. Pederson Bulk culture levels of specific cytotoxic T cell activity against HIV-1 proteins are not associated with risk of death Scand J Immunol 50 1999 223-227
38. + lymphocytes Science 283 1999 857-860
39. + T cell depletion in simian immunodeficiency virus-infected macaques J Exp Med 189 1999 991-998
40. J. Mellors L. Kingsley C. Rinaldo J. Todd V. Hoo R. Kokka P. Gupta Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion Ann Intern Med 122 1995 573-579
41. C. Pederson E. Dickmeiss J. Gaub L.P. Ryder P. Platz B.O. Lindhardt J.D. Lundgren T cell subset alterations and lymphocyte responsiveness to mitogens and antigen during severe primary infection with HIV a case series of seven consecutive HIV seroconverters AIDS 4 1990 523-526
42. K. Ariyoshi E. Harwood R. Chiengsong-Popov J. Weber Is clearance of HIV-1 viremia at seroconversion mediated by neutralising antibodies? Lancet 340 1992 1257-1258
43. + cytotoxic T lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection J Virol 68 1994 6103-6110
44. R. Koup J. Safrit Y. Cao C.A. Andrews G. McLeod W. Borkowsky C. Farthing D.D. Ho Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome J Virol 68 1994 4650-4655
45. C. Van Baalen O. Pontesilli R. Huisman A. Geretti M. Klein F. de Wolf F. Miedema R. Gruters A. Osterhaus Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lypmphocyte frequencies inversely correlate with rapid progression to AIDS J Gen Virol 78 1997 1913-1918
46. + T cells with a predominant Vb usage during the primary immune response to HIV Nature 370 1994 463-467
47. + T cells in acute infectious mononucleosis Nature Med 2 1996 906-911
48. J. Altman P. Moss P. Goulder D. Barouch M. McHeyzer-Williams J.I. Bell A.J. McMichael M.M. Davis Phenotypic analysis of antigen-specific T lymphocytes Science 274 1996 94-96
49. P. Moss S. Rowland-Jones P. Frodsham S. McAdam P. Giangrande A.J. McMichael J.I. Bell Persistent high frequency of human immunodeficiency virus-specific cytolytic T cells in peripheral blood of infected donors Proc Natl Acad Sci USA 92 1995 5773-5777
50. D. Ho A. Neumann A. Perelson W. Chen J.M. Leonard M. Markowitz Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 1995 123-126
51. J. Gamberg I. Bowmer J. Trahey C. Campbell I. Pardoe M. Grant Functional and genetic integrity of the CD8 T cell repertoire in advanced HIV infection AIDS 13 1999 2043-2053
52. M. Klein B. Van A. Holwerda S. Garde R. Bende I. Keet S. Eeftinck A. Osterhaus H. Schuitemaker F. Miedema Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection a longitudinal analysis of rapid progressors and long-term asymptomatics J Exp Med 181 1995 1365-1372
53. C. Rinaldo X. Huang Z. Fan M. Ding L. Beltz A. Logar D. Panicali G. Mazzara J. Liebmann M. Cottrill P. Gupta High levels of anti-HIV-1 memory CTL activity and low viral load are associated with lack of disease in HIV-1-infected long-term non-progressors J Virol 69 1995 5838-5842
54. M. Betts J. Krowka T. Kepler M. Davidian C. Christopherson S. Kwok L. Louie J. Eron H. Sheppard J.A. Frelinger Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors AIDS Res Hum Retroviruses 15 1999 1219-1228
55. R. Wagner B. Leschonsky E. Harrer C. Paulus C. Weber B.D. Walker S. Buchbinder H. Wolf J.R. Kalden T. Harrer Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor constaints on immune escape associated with targeting a sequence essential for viral replication J Immunol 162 1999 3727-3734
56. E. Harrer T. Harrer P. Barbosa M. Feinberg R.P. Johnson S. Buchbinder B.D. Walker Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2 restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor J Infect Dis 173 1996 476-479
57. T. Harrer E. Harrer S. Kalams A. Troch R.P. Johnson T. Elbeik M. Feinberg H. Cao D.D. Ho S. Buchbinder B. Walker Strong cytotoxic T cells and weak neutralising antibodies in long-term non-progressing HIV-1 infection AIDS Res Hum Retroviruses 12 1996 585-592
58. R. Liu W. Paxton S. Chos D. Ceradini S.R. Martin R. Horuk M.E. MacDonald H. Stuhlmann R.A. Koup N.R. Landau Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 86 1996 367-377
59. M. Samson F. Libert B. Doranz J. Rucker C. Liesnard C.M. Farber S. Saragosti C. Lapoumeroulie J. Cognaux C. Forceille G. Muyldermans C. Verhofstede G. Burtonboy M. Georges T. Imai S. Rana Y. Yi R.J. Smyth R.G. Collman R.W. Doms G. Vassart M. Parmentier Resistance of HIV-1 infection in Causian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Nature 382 1996 722-725
60. K. Fowke N. Nagelkerke N. Kimani N. Simonsen A.O. Anzala J. Bwayo J. Oyugi K. MacDonald E. Ngugi F. Plummer Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya Lancet 348 1996 1347-1351
61. N. Bernard C. Yannakis J. Lee C. Tsoukas Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons J Infect Dis 179 1999 538-547
62. Y. Huang W. Paxton S. Wolinsky A. Neumann L. Zhang T. Her S. Kang D. Ceradini Z. Jin K. Yazdanbakhsh K. Kunstman D. Erickson E. Dragon N. landau J. Phair D. Ho R. Koup The role of a mutant CCR5 allele in HIV-1 transmission and disease progression Nature Med 2 1996 1240-1245
63. M. Smith M. Dean M. Carrington C. Winkler G. Huttley D. Lomb J. Goedert T. O'Brien L. Jacobson R. Kaslow S. Buchbinder E. Vittinghoff D. Vlahov K. Hoots M. Hilgartner S. O'Brien Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression Science 277 1997 959-963
64. C. Winkler W. Modi M. Smith G. Nelson X. Wu M. Carrington M. Dean T. Honjo K. Tashiro D. Yabe S. Buchbinder E. Vittinghoff J. Goedert T. O'Brien L. Jacobson R. Detels S. Donfield A. Willoughby E. Gomperts D. Vlahov J. Phair S. O'Brien Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant Science 279 1998 389-394
65. P. Langlade-Demoyen N. Ngo-Giang-Huong F. Ferchal E. Oksenhendler Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients J Clin Invest 93 1994 1293-1297
66. A. De Maria C. Cirillo L. Moretta Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers J Infect Dis 170 1994 1296-1299
67. L. Pinto J. Sullivan J. Berzofsky M. Clerici H.A. Kessler A.L. Landay G.M. Shearer Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids J Clin Invest 96 1995 867-876
68. S. Rowland-Jones J. Sutton K. Ariyoshi T. Dong F.M. Gotch S. McAdam D. Whitby S. Sabally A. Gallimore T. Corrah M. Takiguchi T. Schultz A. McMichael H. Whittle HIV-specific cytotoxic T cells in HIV-exposed but uninfected Gambian women Nature Med 1 1995 59-64
69. J. Salk P. Bretscher P. Salk M. Clerici G. Shearer A strategy for prophylactic vaccination against HIV Science 260 1993 1270-1272
70. T. Greenough D. Brettler M. Somasundaran D. Panicali J. Sullivan Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss evidence supporting a protective role for CTL in vivo J Infect Dis 176 1997 118-125
71. L. Musey J. Hughes T. Schacker T. Shea L. Corey M.J. McElrath Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection N Engl J Med 337 1997 1267-1274
72. - phenotype comparison of statistical methods for measurement JAIDS 22 1999 19-30
73. S.A. Kalams S.P. Buchbinder E.S. Rosenberg J.M. Billingsley D.S. Colbert N.G. Jones A.K. Shea A.K. Trocha B.D. Walker Association between virus-specific cytotoxic T lymphocyte and helper responses in human immunodeficiency virus type 1 infection J Virol 73 1999 6715-6720
74. + T cell numbers in progression of HIV type 1 infection AIDS Res Hum Retroviruses 14 1998 1423-1433
75. G.S. Ogg X. Jin S. Bonhoeffer P.R. Dunbar M.A. Nowak S. Monard J.P. Segal Y. Cao S.L. Rowland-Jones V. Cerundolo A. Hurley M. Markowitz D.D. Ho D.F. Nixon A.J. McMichael Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA Science 279 1998 2103-2106
76. G.S. Ogg S. Kostense M.R. Klein S. Jurriaans D. Hamann A.J. McMichael F. Miedema Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes correlation with disease progression J Virol 73 1999 9153-9160
77. D.D. Kostyu L.I. Hannick J.L. Traweek M. Ghanayem D. Heilpern D.V. Dawson HLA class I polymorphism structure and function and still questions Hum Immunol 57 1997 1-18
78. A. Hill HIV and HLA confusion or complexity? Nat Med 2 1996 395-396
79. M. Roger Influence of host genes on HIV-1 disease progression FASEB J 12 1998 625-632
80. H. Hendel S. Caillat-Zucman H. Lebuanec M. Carrington S. O'Brien J.M. Andrieu F. Schachter D. Zagury J. Rappaport C. Winkler G.W. Nelson J.F. Zagury New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS J Immunol 162 1999 6942-6946
81. R. Kaslow M. Carrington R. Apple L. Park A. Munoz A.J. Saah J.J. Goedert C. Winkler S.J. O'Brien C. Rinaldo R. Detels W. Blattner J. Phair H. Erlich D.L. Mann Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection Nature Med 2 1996 405-411
82. R. Scorza Smeraldi G. Fabio A. Lazzarin N.B. Eisera M. Moroni C. Zanussi HLA-associated susceptibility to AIDS in Italian patients with HIV infection Lancet 2 1986 1187-1189
83. M. Carrington G.W. Nelson M.P. Martin T. Kissner D. Vlahov J.J. Goedert R. Kaslow S. Buchbinder K. Hoots S.J. O'Brien HLA and HIV-1 heterozygote advantage and B*35-Cw*04 disadvantage Science 283 1999 1748-1752
84. X. Wei S. Ghosh M. Taylor V.A. Johnson E.A. Emini P. Deutch J.D. Lifson S. Bonhoeffer M.A. Nowak B.H. Hahn Viral dynamics in human immunodeficiency virus type 1 infection Nature 373 1995 117-122
85. J. Coffin HIV population dynamics in vivo implications for genetic variation, pathogenesis and therapy Science 267 1995 483-489
86. M. Kozal N. Shah N. Shen R. Yang R. Fucini T.C. Merigan D.D. Richman D. Morris E. Hubbell M. Chee T.R. Gingeras Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays Nature Med 2 1996 753-759
87. A. Meyerhans G. Dadaglio J. Vartanian P. Langlade-Demoyen R. Frank B. Asjo F. Plata S. Wain-Hobson In vivo persistence of HIV-1 encoded HLA-B27-restricted cytolytic T lymphocyte epitope despite specific in vitro reactivity Eur J Immunol 21 1991 2637-2640
88. Z.W. Chen L. Shen M.D. Miller S.H. Ghim A.L. Hughes N.L. Letvin Cytolytic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag J Immunol 149 1992 4060-4066
89. P. Borrow H. Lewicki X. Wei M.S. Horwitz N. Peffer H. Meyers J.A. Nelson J.E. Gairin B.H. Hahn M.B.A. Oldstone G.M. Shaw Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTL) during primary infection demonstrated by rapid selection of CTL escape virus Nature Med 2 1997 205-211
90. D. Price P. Goulder P. Klenerman A.K. Sewell P.J. Easterbrook M. Troop C.R.M. Bangham R.E. Phillips Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection Proc Natl Acad Sci USA 94 1997 1890-1895
91. S. Koenig A. Conley Y. Brewah G.M. Jones S. Leath L.J. Boots V. Davey G. Pantaleo J.F. Demarest C. Carter C. Wannebo J.R. Yannelli S.A. Rosenberg H.C. Lane Transfer of HIV-1 specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression Nature Med 1 1995 330-336
92. D. Evans D. O'Connor P. Jing J. Dzuris J. Sidney J. Da Silva T. Allen H. Horton J. Venham R. Rudersdorf T. Vogel C. Pauza R. Bontrop R. DeMars A. Sette A. Huges D. Watkins Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef Nature Med 5 1999 1270-1276
93. D. Moskophidis F. Lechner H. Pircher R. Zinkernagel Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells Nature 362 1993 758-761
94. + T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity Proc Natl Acad Sci USA 87 1990 4818-4822
95. N. Perillo R. Walford N. Newman R. Effros Human T lymphocytes possess a limited in vitro lifespan Exp Gerontol 24 1989 177-187
96. K. Wolthers F. Miedema Telomeres and HIV infection in search of exhaustion Trends Microbiol 6 1998 144-147
97. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis AIDS 10 1996 F17-F22
98. + T cell clones during primary HIV infection Proc Natl Acad Sci USA 94 1997 9848-9853
99. T.H. Finkel G. Tudor-Williams N.K. Banda M.F. Cotton T. Curiel C. Monks T.W. Baba R.M. Ruprecht A. Kupfer Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes Nature Med 1 1995 1129-1134
100. R. Gehri S. Hahn M. Rothen M. Steuerwald R. Neusch P. Erb The Fas receptor in HIV infection expression on peripheral blood lymphocytes and role in the depletion of T cells AIDS 10 1996 9-16
101. A.D. Badley J.A. McElhinny P.J. Leibson D.H. Lynch M.R. Alderson C.V. Paya Upregulation of fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes J Virol 70 1996 199-206
102. + T cells in vitro and in vivo association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid Immunology 87 1996 581-585
103. S. Strand W.J. Hofmann H. Hug M. Muller G. Otto D. Strand S.M. Mariani W. Stremmel P.H. Krammer P.R. Galle Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells a mechanism of immune evasion? Nature Med 2 1996 1361-1366
104. X. Xu G. Screaton F. Gotch T. Dong R. Tan N. Almond R. Stebbings K. Kent S. Nagata J.E. Stott A.J. McMichael Evasion of cytotoxic T lymphocyte (CTL) responses by Nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells J Exp Med 186 1997 7-16
105. R. Tan X. Xu G.S. Ogg P. Hansasuta T. Dong T. Rostron G. Luzzi C.P. Conlon G.R. Screaton A.J. McMichael S. Rowland-Jones Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome Blood 93 1999 1506-1510
106. + CTL clones is limited by elimination due to encounter with HIV-infected targets J Immunol 163 1999 861-867
107. M.D. Grant F.M. Smaill D.P. Singal K.L. Rosenthal The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T cell activity in HIV-1 infected subjects AIDS 6 1992 1085-1094
108. C.M. Hay D.J. Ruhl N.O. Basgoz C.C. Wilson J.M. Billingsley M.P. DePasquale R.T. D'Aquila S.M. Wolinsky J.M. Crawford D.C. Montefiori B.D. Walker Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection J Virol 73 1999 5509-5519
109. A. Fauci G. Pantaleo S. Stanley D. Weissman Immunopathogenic mechanisms of HIV infection Ann Internal Med 124 1996 654-663
110. + T cell responses associated with control of viremia Science 278 1997 1447-1450
111. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression Nature Med 5 1999 518-525
112. S. Riddell M. Elliott D. Lewinsohn M. Gilbert L. Wilson S.A. Manley S.D. Lupton R.W. Overell T.C. Reynolds L. Corey P.D. Greenberg T cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients Nature Med 2 1996 216-223
113. + cytotoxic T cell responses during chronic viral infection J Virol 68 1994 8056-8063
114. T. Ishikawa D. Kono J. Chung P. Fowler A. Theofilopoulos S. Kakumu F. Chisari Polyclonality and multispecificity of the CTL response to a single viral epitope J Immunol 161 1998 5842-5850
115. I. Couillin F. Connan P.B. Culmann E. Gomard J.G. Guillet J. Choppin HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding Eur J Immunol 25 1995 728-732
116. U.C. Meier P. Klenerman P. Griffin W. James B. Koppe B. Larder A.J. McMichael R. Phillips T cell receptor antagonism by variable human immunodeficiency viruses Science 270 1995 1360-1362
117. M.A. Nowak R.M. May R.E. Phillips S. Rowland-Jones D.G. Lalloo S. McAdam P. Klenerman B. Koeppe K. Sigmund C.R.M. Bangham A.J. McMichael Antigenic oscillations and shifting immunodominance in HIV-1 infections Nature 375 1995 606-611
118. G. Haas U. Plikat P. Debre M. Lucchiari C. Katlama Y. Dudoit O. Bonduelle M. Bauer H.G. Ihlenfeldt G. Jung B. Maier A. Meyerhans B. Autran Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo J Immunol 157 1996 4212-4221
119. D.A. Price U.C. Meier P. Klenerman M.A. Purbhoo R.E. Phillips A.K. Sewell The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection J Mol Med 76 1998 699-708
120. R.E. Phillips S. Rowland-Jones D.F. Nixon F.M. Gotch J.P. Edwards A.O. Ogunlesi J.G. Elvin J.A. Rothbard C.R.M. Bangham C.R. Rizza A.J. McMichael Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition Nature 354 1991 453-459
121. S. McAdam P. Klenerman L. Tussey S. Rowland-Jones D. Lalloo R. Phillips A. Edwards P. Giangrande A. Leigh-Brown F. Gotch A. McMichael Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses J Immunol 155 1995 2729-2736
122. P. Klenerman U.C. Meier R.E. Phillips A.J. McMichael The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus Eur J Immunol 25 1995 1927-1931
123. M.A. Purbhoo A.K. Sewell P. Klenerman P.J.R. Goulder K.L. Hilyard J.I. Bell B.K. Jakobsen R.E. Phillips Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade Proc Natl Acad Sci USA 95 1998 4527-4532
124. P. Klenerman R.M. Zinkernagel Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes Nature 394 1998 482-485
125. T. Kerkau R. Schmitt-Landgraf A. Schimpl I. Wecker Downregulation of HLA class I antigens in HIV-1 infected cells AIDS Res Hum Retroviruses 5 1989 613-620
126. + T cell line, CEM-E5, after HIV-1 infection J Immunol 143 1989 2858-2866
127. T.K. Howcroft K. Strebel M.A. Martin D.S. Singer Repression of MHC class I gene promoter activity by two-exon tat of HIV Science 260 1993 1320-1322
128. T. Kerkau I. Bacik J.R. Bennink J.W. Yewdell T. Hunig A. Schimpl U. Schubert The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules J Exp Med 185 1997 1295-1305
129. O. Schwartz V. Marechal S. LeGall F. Lemonnier J.M. Heard Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein Nature Med 2 1996 338-342
130. K.L. Collins B.K. Chen S.A. Kalams B.D. Walker D. Baltimore HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes Nature 391 1998 397-401
131. F.J. Palella Jr K.M. Delaney A.C. Moorman M.O. Loveless J. Fuhrer G.A. Satten D.J. Aschman S.D. Holmberg Declining morbidity and mortality among patients with advanced human immunodeficiency virus infections N Engl J Med 338 1998 853-860
132. T.S. Li R. Tubiana C. Katlama V. Calvez H.A. Mohand B. Autran Long-lasting recovery in CD4 T cell function and viral load reduction after highly active antiretroviral therapy in advanced HIV-1 disease Lancet 351 1998 1682-1686
133. + T cell homeostasis and function in advanced HIV disease Science 277 1997 112-116
134. M.A. Jacobson M. Zegans P.R. Pavan J.J. O'Donnell F. Sattler N. Rao S. Owens R. Pollard Cytomegalovirus retinitis after initiation of highly active antiretoviral therapy Lancet 349 1997 1443-1445
135. I. Mezzaroma M. Carlesimo E. Pinter C. Alario G. Sacco D.S. Muratori M.L. Bernardi R. Paganelli F. Aiuti Long-term evaluation of T cell subsets and T cell function after HAART in advanced stage HIV-1 disease AIDS 13 1999 1187-1193
136. S.A. Kalams P.J. Goulder A.K. Shea N.G. Jones A.K. Trocha G.S. Ogg B.D. Walker Levels of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy J Virol 73 1999 6721-6728
137. + T cells in individuals receiving highly active antiretroviral therapy (HAART) J Immunol 162 1999 1780-1788
138. G.S. Ogg X. Jin S. Bonhoeffer P. Moss M.A. Nowak S. Monard J.P. Segal Y. Cao S. Rowland-Jones A. Hurley M. Markowitz D.D. Ho A.J. McMichael D.F. Nixon Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy J Virol 73 1999 797-800
139. M. Dalod M. Harzic I. Pellegrin B. Dumon B. Hoen D. Sereni J.C. Deschemin J.P. Levy A. Venet E. Gomard Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy J Infec Dis 178 1998 61-69
140. S.R. Sondergaard H. Aladdin H. Ullum J. Gerstoft P. Skinhoj B.K. Pedersen Immune function and phenotype before and after highly active antiretroviral therapy JAIDS 21 1999 376-383
141. H. Ullum T. Katzenstein H. Aladdin C. Nielsen S.R. Sondergaard J. Gerstoft P. Skinhoj B.K. Pedersen Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment Scand J Immunol 49 1999 539-547
142. + T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA AIDS Res Hum Retroviruses 15 1999 963-972
143. D.C. Douek R.D. McFarland P.H. Keiser E.A. Gage J.M. Massey B.F. Haynes M.A. Polis A.T. Haase M.B. Feinberg J.L. Sullivan B.D. Jamieson J.A. Zack L.J. Picker R.A. Koup Changes in thymic function with age and during the treatment of HIV infection Nature 396 1998 690-695